Gail Larkins

Gail Larkins is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the Executive Director and Head of Global Medical Capabilities at BioCryst Pharmaceuticals, Inc. since February 2024. Larkins held various advisory and consulting roles in 2023, including Strategic Advisor at Primum and Advisor at Redesign Health. Prior to these positions, Larkins was the VP of Medical Affairs at Verastem Oncology and Global Head of Medical Planning and Operations at Acceleron Pharma, which was acquired by Merck. Larkins' extensive background includes leadership roles at Bristol Myers Squibb and Celgene, focusing on medical affairs, commercial strategy, and clinical development. Larkins holds an MBA in Marketing from Seton Hall University and a B.S. in Nursing from Kean University.